Information  X 
Enter a valid email address

Puretech Health PLC Ord 1P (PRTC)

Date Time Source Announcement
17 Feb 2022 12:05 pm
RNS
Akili Data: Enhanced Brain Activity in Kids w/ADHD
15 Feb 2022 7:00 am
RNS
PRTC's Akili Files Registration Statement on S-4
10 Feb 2022 12:00 pm
RNS
PRTC to Present at Leerink Healthcare Conference
04 Feb 2022 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
31 Jan 2022 11:50 am
RNS
PRTC's Gelesis Launches Plenity Media Campaign
26 Jan 2022 12:02 pm
RNS
PRTC's Akili to Become Public & $162M Funding
14 Jan 2022 7:00 am
RNS
PRTC's Gelesis to Debut on NYSE Today Ticker GLS
07 Jan 2022 12:00 pm
RNS
PureTech to Present at JPM Healthcare Conference
06 Jan 2022 7:00 am
RNS
LYT-100 Shows Improved AE Profile vs Pirfenidone
05 Jan 2022 12:05 pm
RNS
Gelesis Adds to BOD & Declared Effective by SEC
20 Dec 2021 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
16 Dec 2021 7:00 am
RNS
PRTC Provides Recap Ahead of Catalyst-Rich 2022
08 Dec 2021 12:00 pm
RNS
PRTC Presents Data at ACNP Conference For LYT-300
07 Dec 2021 12:00 pm
RNS
PRTC's Lymphatic Platform Candidate Human Study
01 Dec 2021 12:10 pm
RNS
PRTC: Gelesis' Plenity Now Broadly Available in US
  7:00 am
RNS
Total Voting Rights
18 Nov 2021 12:10 pm
RNS
PRTC's Gelesis Receives $30M Plenity Order from Ro
16 Nov 2021 12:00 pm
RNS
PRTC Publishes Previous LYT-100 MAD Study Results
15 Nov 2021 12:00 pm
RNS
PRTC Presents at Two Upcoming Investor Conferences
12 Nov 2021 12:00 pm
RNS
PRTC Presents Immunooncology Ph 1/2 Trial at SITC
11 Nov 2021 12:00 pm
RNS
FDA Grants PRTC's LYT-200 Orphan Drug Designation
10 Nov 2021 7:00 am
RNS
PRTC Receives $100M from Founded Entity Shares
09 Nov 2021 12:34 pm
RNS
KRTX and Zai Lab to Develop KarXT in Greater China
  7:00 am
RNS
PRTC Presents at Jefferies Healthcare Conference
01 Nov 2021 10:20 am
RNS
New Research in Journal Nature on Gelesis Tech
  7:00 am
RNS
Total Voting Rights
22 Oct 2021 6:00 pm
RNS
Holdings in Company - TR-1 Correction Announcement
20 Oct 2021 4:35 pm
RNS
Price Monitoring Extension
14 Oct 2021 12:01 pm
RNS
PRTC's Vedanta Appoints Chief Legal Officer
12 Oct 2021 7:00 am
RNS
Additional Listing
05 Oct 2021 1:01 pm
RNS
Vedanta Positive Phase 2 Data in C. Diff Infection
  1:00 pm
RNS
PRTC's Sonde Launches Mental Health Monitor
29 Sep 2021 1:01 pm
RNS
Akili/Shionogi Report Positive Ph2 Data in Japan
20 Sep 2021 4:02 pm
RNS
New PureTech Research Published In Nature Journal
14 Sep 2021 12:00 pm
RNS
PRTC to Present at Oppenheimer Healthcare Summit
10 Sep 2021 7:00 am
RNS
PRTC's Vor Granted FDA Fast Track Designation
01 Sep 2021 7:00 am
RNS
Total Voting Rights
24 Aug 2021 7:00 am
RNS
Half-year Report
23 Aug 2021 12:00 pm
RNS
PRTC Presents LYT-100 Ph1 PK & Tolerability at ERS
17 Aug 2021 1:03 pm
RNS
Akili Deal Furthers Digital Medicine Leadership
13 Aug 2021 12:00 pm
RNS
PRTC Appoints Industry Veteran & Physician as CMO
11 Aug 2021 12:00 pm
RNS
PRTC Receives $6.5M; Imbrium to Develop LYT-503
03 Aug 2021 7:00 am
RNS
Notice of Results
02 Aug 2021 7:00 am
RNS
Total Voting Rights
23 Jul 2021 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
22 Jul 2021 1:03 pm
RNS
PRTC's Akili Releases New Features for EndeavorRx
  7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
21 Jul 2021 12:03 pm
RNS
PureTech's Vedanta Raises $68M Series D Financing
19 Jul 2021 12:02 pm
RNS
PRTC's Gelesis to Become Public Via Capstar SPAC
09 Jul 2021 12:00 pm
RNS
PRTC's Vor Announces Collaboration with Janssen
08 Jul 2021 2:05 pm
RNS
PRTC's Sonde Announces Collaboration With Qualcomm
07 Jul 2021 12:00 pm
RNS
PRTC BeiGene LYT-200 Clinical Trial Agreement
01 Jul 2021 7:00 am
RNS
Total Voting Rights
30 Jun 2021 12:00 pm
RNS
PRTC's Vedanta Announces New Data from IBD Study
28 Jun 2021 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
24 Jun 2021 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
23 Jun 2021 1:28 pm
RNS
Karuna Announces KarXT Results in Healthy Elderly
16 Jun 2021 12:00 pm
RNS
PureTech Acquires Alivio and Oral IL-22 Candidate
02 Jun 2021 7:00 am
RNS
PDMR Notification RSU Vesting
01 Jun 2021 7:00 am
RNS
Total Voting Rights

a d v e r t i s e m e n t